Results 81 to 90 of about 306,744 (280)

Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different?

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1447-1454, April 2025.
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo   +10 more
wiley   +1 more source

Unusual pattern of thrombotic events in young adult non‐critically ill patients with COVID‐19 may result from an undiagnosed inherited and acquired form of thrombophilia

open access: yesBritish Journal of Haematology, 2021
In 145 previously healthy non‐critically ill young adults, coronavirus disease 2019 (COVID‐19)‐related symptoms, risk factors for thrombosis, coagulation and inflammatory parameters were compared, with 29 patients reporting unusual thrombotic events ...
M. Elbadry   +8 more
semanticscholar   +1 more source

Gout in pregnancy: Obstetric and neonatal outcomes

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 349-355, April 2025.
Abstract Objective The pregnancy, delivery, and neonatal outcomes of pregnancies complicated by gout have yet to be evaluated in a population‐based study. We sought to evaluate the obstetric and neonatal outcomes in pregnant patients with gout using a national population database.
Sam Amar   +3 more
wiley   +1 more source

Comment on: Inherited Thrombophilia and Pregnancy Complications: Should We Test?

open access: yesSeminars in Thrombosis and Hemostasis, 2019
I read the paper by Arachchillage and Makris, entitled “Inherited Thrombophilia and Pregnancy Complications: ShouldWe Test,” with interest.1 The paper deals with several inherited thrombophilic conditions which may lead to obstetric complications and ...
G. Ruiz-Argüelles
semanticscholar   +1 more source

Uncovering the role of genetic polymorphisms in cervical insufficiency

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Pathways and genes implicated in CI pathogenesis. Abstract Cervical insufficiency (CI) is characterized by spontaneous dilation of the cervix in the absence of painful uterine contractions in the mid‐trimester, leading to premature delivery. It is responsible for up to 20% of second trimester pregnancy losses, mostly <24 weeks.
Kallirhoe Kalinderi   +3 more
wiley   +1 more source

Cardiovascular risk profile according to World Health Organization medical eligibility criteria for contraceptive use of women using hormonal contraception in Rio de Janeiro state, Brazil

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Hormonal contraception, especially combined oral contraceptives, is associated with an increase in cardiovascular risk. Thus, we aimed to analyze the use of hormonal contraceptive methods in the state of Rio de Janeiro (Brazil), with a focus on determining whether contraceptive use follows the cardiovascular profile of women ...
Isabela Pereira Fonseca Brusth   +2 more
wiley   +1 more source

Guidelines on fibrinogen assays [PDF]

open access: yes, 2003
No abstract ...
Becker   +52 more
core   +1 more source

Inherited thrombophilia and the risk of myocardial infarction: current evidence and uncertainties.

open access: yesKardiologia polska, 2019
Atherothrombotic diseases (ATEs) and venous thromboembolism (VTE) have been traditionally considered to have a distinct pathogenesis. Today, a growing body of evidence on the pathophysiology of thrombus formation has convincingly proved that they share ...
Z. Bereczky, L. Balogh, Z. Bagoly
semanticscholar   +1 more source

Antithrombin: Deficiency, Diversity, and the Future of Diagnostics

open access: yesMass Spectrometry Reviews, EarlyView.
ABSTRACT Our healthcare system provides reactive sick‐care, treating patients after symptoms have appeared by prescription of generic and often suboptimal therapy. This strategy brings along high costs and high pressure which is not sustainable.
Mirjam Kruijt   +2 more
wiley   +1 more source

Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study [PDF]

open access: yes, 2005
Combined oral contraceptives,oral hormone replacement therapy and thrombophilias are recognised risk factors for venous thromboembolism in women.The objective of this study was to assess the risk of thromboembolism among women with thrombophilia who are ...
Brenkel, I.   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy